ACHN—It’s all at the 5/19/2014 UBS [webcast]—slides #8-13.
Thanks for the citation wrt ACH-3422’s preclinical data, which I have yet to examine. Please note that your post in #msg-103194547 responded to only one of the two conditions about this drug that I posited in #msg-103186964. Regards, Dew